Skip to main content

What to know about CMS’ 2022 rules

Key takeaways from five final and two proposed rules from CMS

CMS adopted five final Medicare Prospective Payment System rules for FFY 2022 and proposed two rules for calendar year 2022.

DataGen has interpreted and analyzed each of the final and proposed rules to help you gauge how these changes may impact your organization.
These rules include regular updates to the wage index and other significant items listed below.
  • The Inpatient PPS final rule includes the following proposals:
    • rebasing and revising the IPPS marketbasket and the Capital Input Price Index from FFY 2014 cost report data to FFY 2018 data;
    • rate increase (+0.5%) for the Medicare Access and CHIP Reauthorization Act of 2015 coding offset adjustment;
    • nonstandard adjustments to hospital wage indexes (for eligible hospitals) including bottom quartile adjustments, a 5% wage index “stop-loss” and the reintroduction of an imputed floor policy as mandated by the Consolidated Appropriations Act of 2021;
    • updates to Medicare Disproportionate Share Hospital payment policies, including hospitals being eligible for DSH payments in FFY 2022 based on audited FFY 2018 S-10 data;
    • repealing the policy requiring hospitals to report the median payer-specific negotiated rates for inpatient services by Medicare Severity Diagnosis Related Group for Medicare Advantage organizations on the Medicare cost report; and
    • modifying limitations on redesignation by the Medicare Geographic Classification Review Board.
  • The Long Term-Care Hospital PPS final rule includes: beginning in FFY 2021, the Bipartisan Budget Act of 2018 mandates an IPPS equivalent payment rate for all discharges for LTCHs with fewer than 50% of their cases eligible for LTCH standard payment.
  • The CY 2022 Outpatient PPS proposed rule includes:
    • halting the elimination of the Inpatient Only list and adding back in services removed in CY 2021;
    • creation of a universal low volume Ambulatory Payment Classification policy;
    • amending price transparency requirements; and
    • changes to the Radiation Oncology model.
  • The CY 2022 Home Health PPS proposed rule includes:
    • recalibration of the Patient-Driven Grouping Model case-mix weights, functional levels and comorbidity adjustment subgroups; and
    • expansion of the HH VBP program to all Medicare-certified HHAs, with CY 2022 being the first performance year and CY 2024 being the first payment adjustment year.
  • All payment settings include the use of a COVID-19 Vaccination Coverage among Healthcare Personnel measure in quality programs. Due to the pandemic, CMS is suppressing the Hospital Inpatient and SNF Value-Based Purchasing programs for 2022.
DataGen has published briefs on all of these rules and analyzed provider-specific estimated reimbursement impacts for each payment setting. Generally, providers use the proposed rule analyses for advocacy and education on what CMS is planning, whereas the final rule analyses are used for budgeting.

Table 1: FFY 2022 Medicare IPPS Final Rule Analysis





Estimated FFY 2021 IPPS payments




Estimated FFY 2022 IPPS payments




Total estimated change FFY 2021 to FFY 2022*







*The values shown in the table do not include the 2.0% sequestration reduction to all lines of Medicare payment authorized by Congress through FFY 2031. As part of the Medicare Sequester Relief Act, Congress eliminated the 2% sequester on Medicare payments from Oct. 1, 2021 through Dec. 31, 2021. The estimated reduction due to sequestration for FFY 2022 IPPS-specific payments will be: $1,913,437,300.

Table 1 shows the estimated change in Medicare payments for FFY 2022 under the IPPS. Compared to FFY 2021, both the dollar impact amounts for operating and capital are projected to increase. This analysis is particularly important for all providers to make educated budgeting decisions.

For more information, including our projections for all care settings, contact DataGen and follow us on LinkedIn.


Popular posts from this blog

BPCI Advanced – take advantage of the model extension now

The Bundled Payment for Care Improvement (BPCI) Advanced Model is now open for applications until May 31, 2023. This model provides a unique opportunity to acute care hospitals and physician group practices who are looking to: evaluate their bundle performance; rejoin if they have previously dropped out due to being under a convener; or take advantage of the changes to the model. With a small window to sign the participation agreement, you’ll need experts to process data quickly and accurately for evaluation. BPCI Advanced Program Details The Centers for Medicare & Medicaid Services (CMS) announced in October 2022 that this program will extend from January 2024 to December 2025. Data used for evaluation will be taken from the baseline period between October 2018 and September 2022. A participation agreement will be sent out in September 2023 and needs to be signed by October 2023 in order to participate. Those who apply before the May 31 deadline will benefit

You’ve been accepted to the Enhancing Oncology Model. Now what?

The Centers for Medicare and Medicaid Services Innovation Center recently announced approved applicants for the new Enhancing Oncology Model. If your facility has been selected by CMS, are you still weighing your options during the current baseline evaluation period?  Two deciding factors may include the program data that CMS provides and whether EOM is enough of an improvement over the prior Oncology Care Model to make your investment worthwhile. Another factor to consider: Will you have the resources in place to conduct a baseline evaluation before EOM’s program start on July 1, 2023? How EOM differs from OCM EOM aims to improve the coordination of oncology care, drive practice transformation and reduce Medicare fee-for-service spending through episode-based payment. It includes three major updates: Fewer cancer types. Compared with OCM’s 21, EOM will be limited to seven common cancer types: breast, prostate, lung, small intestine/colorectal, multiple myeloma, lymphoma and chronic le

3 Major Areas to Focus on After Receiving NCQA PCMH Recognition

First off, congratulations to you and your practice for achieving National Committee for Quality Assurance Patient-Centered Medical Home recognition! Gaining NCQA PCMH status is a big accomplishment for which you should be very proud. Now that you’ve completed the necessary steps to implement changes and earn recognition, you may be wondering what’s next. In this guide, we’ll navigate what to do next, PCMH standards and guidelines to follow and 2024 annual reporting requirements to focus on. Let’s get into it! What to do after earning NCQA PCMH recognition Before you’re ready to start earning the great benefits of PCMH recognition , you need to plan what actions you’ll take to maintain your status. Remember, PCMH is not a project, but a continual progression of the way care is delivered to patients, meeting them where they are. So, if you’re a practice that wishes to keep its PCMH, you’ll need to be accountable for each criterion you achieved when initially receiving PCMH recognition.